Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides

Pharmaceutical Research

Volumn 17, Issue 6, 2000, Pages 707-714

  Lambert, Gregory ^a   Fattal, Elias ^a   Pinto Alphandary, Huguette ^a   Gulik, Annette ^b   Couvreur, Patrick ^a  

^a UNIV PARIS SUD   (France)

^b CNRS   (France)

Author keywords

Antisense; Nanocapsules; Nanoparticles; Nanospheres; Oligonucleotides; Polyisobutylcyanoacrylate

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BUCRILATE; CALCEIN; CETRIMIDE; CYANOACRYLATE DERIVATIVE; DEXTRAN 70; FLUORESCEIN; MIGLYOL; NANOCAPSULE; NANOPARTICLE; SORBITAN OLEATE; WATER OIL CREAM;

ADSORPTION; AQUEOUS SOLUTION; ARTICLE; COLLOID; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ENZYME DEGRADATION; FLUORESCENCE; MICROENCAPSULATION; POLYMERIZATION; PRIORITY JOURNAL; SUSPENSION; ULTRACENTRIFUGATION; ZETA POTENTIAL;

COLLOIDS; CYANOACRYLATES; DRUG CARRIERS; FLUORESCEINS; FLUORESCENCE; OLIGONUCLEOTIDES; PARTICLE SIZE; POLYMERS;

EID: 0033840158     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007582332491     Document Type: Article

References (30)

1. Antisense oligonucleotides: A new therapeutic approach
2. Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression
3. Antitumor activity of a PKC-alpha antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted into nude mice
4. The multiple inhibitory mechanisms of GEM 91, a gag antisense phosphorothioate oligonucleotide, for human immunodeficiency virus type 1
5. Definition by specific antisense oligonucleotides of a role for protein kinase C alpha in expression of differentiation markers in normal and neoplastic mouse epidermal keratinocytes
6. Antisense pharmacodynamics: Critical issues in the transport and delivery of antisense oligonucleotides
7. Backbone modifications in oligonucleotides and peptide nucleic acid systems
8. Phosphorothioate oligodeoxynucleotides: Antisense or anti-protein?
9. Phosphorothioate antisense oligodeoxynucleotides: Questions of specificity
10. Regulatory considerations for oligonucleotide drugs: Updated recommendations for pharmacology and toxicology studies
11. Synthetic oligonucleotides: The development of antisense therapeutics
12. Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides
13. Spongelike alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotides
14. Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides
15. Pharmacokinetics and biodistribution of oligonucleotide adsorbed onto poly(isobutylcyanoacrylate) nanoparticles after intravenous administration in mice
16. Adsorption of single-strand DNA fragments onto cationic aminated latex particles
17. Nanocapsules formation by interfacial polymer deposition following solvent displacement
18. Preparation and characterization of nanocapsules from preformed polymers by a new process based on emulsification-diffusion technique
19. Development of a new process for the manufacture of polyisobutylcyanoacrylate nanocapsules
20. A new nanocapsule formulation with hydrophilic core: Application to the oral administration of salmon calcitonin in rats
21. Development of a quantitative polyacrylamide gel electrophoresis analysis using a multichannel radioactivity counter for the evaluation of oligonucleotide-bound drug carrier
22. Effect of polyisobutylcyanoacrylate nanoparticles and lipofectin loaded with oligonucleotides on cell viability and PKC alpha neosynthesis in HepG2 cells
23. Solute perturbation of protein fluorescence. The quenching of the tryptophyl fluorescence of model compounds and of lysozyme by iodide ion
24. Solvent perturbation of the fluorescence of fluorescein bound to specific antibody. Fluorescence quenching of the bound fluorophore by iodide
25. In vitro model for the degradation of alkylcyanoacrylate nanoparticles
26. Degradation of poly (isobutyl cyanoacrylate) nanoparticles
27. Adsorption of oligonucleotides onto polyisohexylcyanoacrylate nanoparticles protects them against nucleases and increases their cellular uptake
28. Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice
29. Cationic liposome-encapsulated antisense oligonucleotide mediates efficient killing of intracellular Leishmania
30. Adsorption of antineoplastic drugs to polyalkylcyanoacrylate nanoparticles and their release in calf serum